Top Suppliers:I want be here
Related CAS#:
242478-38-2 862207-70-3
1262506-09-1 1225338-27-1
1956436-64-8 1427376-05-3
180272-28-0 1426174-05-1
242478-37-1 1251905-45-9

242478-38-2

242478-38-2 structure
242478-38-2 structure
  • Name: solifenacin succinate
  • Chemical Name: Solifenacin succinate
  • CAS Number: 242478-38-2
  • Molecular Formula: C27H32N2O6
  • Molecular Weight: 480.553
  • Catalog: Biochemical Inhibitor Neuronal Signaling AChR antagonist
  • Create Date: 2018-09-22 16:23:19
  • Modify Date: 2024-01-02 14:13:18
  • Solifenacin Succinate(YM905; Vesicare) is a muscarinic receptor antagonist.IC50 value:Target: muscarinic receptorSolifenacin succinate (YM905; Vesicare) is a prescription medication used to treat certain bladder problems.
Name Solifenacin succinate
Synonyms 1-Azabicyclo[2.2.2]octan-8-yl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate butanedioic acid
(1R,3R)-1-azabicyclo[2.2.2]octan-3-yl (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate
(3R)-1-Azabicyclo[2.2.2]oct-3-yl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate butanedioate
2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester, (1S)-, butanedioate (1:1)
Succinic acid - (3R)-1-azabicyclo[2.2.2]oct-3-yl (1S)-1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate (1:1)
solifenacin succinate
Vesikur
Solifenacin succinate [USAN]
T66 CNT&J BR& CVO- AT66 A B CNTJ &&(1S)-(3R)- Form succinate
Butanedioic acid, compd with (1S)-(3R)-1-azabicyclo(2.2.2)oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate (1:1)
IsoprenalinoeSulfate
(1S)-(3R)-1-Azabicyclo[2.2.2]oct-3-yl 3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate Butanedioic Acid
Vesicare
Solifenacin (Succinate)
Description Solifenacin Succinate(YM905; Vesicare) is a muscarinic receptor antagonist.IC50 value:Target: muscarinic receptorSolifenacin succinate (YM905; Vesicare) is a prescription medication used to treat certain bladder problems.
Related Catalog
References

[1]. Krishna SR, Rao BM, Rao NS.A validated rapid stability-indicating method for the determination of related substances in solifenacin succinate by ultra-fast liquid chromatography.J Chromatogr Sci. 2010 Nov;48(10):807-10.

[2]. Ohtake A, Sato S, Sasamata M, Miyata K.The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: ameliorative effect of solifenacin succinate (Vesicare), a bladder-selective antimuscarinic agent, on overactive bladder symptoms, especially urgency episodes.J Pharmacol Sci. 2010;112(2):135-41. Epub 2010 Feb 4.

[3]. Hoffstetter S, Leong FC.Solifenacin succinate for the treatment of overactive bladder.Expert Opin Drug Metab Toxicol. 2009 Mar;5(3):345-50.

[4]. Choo MS, Lee JZ, Lee JB, Kim YH, Jung HC, Lee KS, Kim JC, Seo JT, Paick JS, Kim HJ, Na YG, Lee JG.Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study.Int J Clin Pract. 2008 Nov;62(11):1675-83.

[5]. Imamura T, et al.Combined treatment with a β3 -adrenergic receptor agonist and a muscarinic receptor antagonist inhibits detrusor overactivity induced by cold stress in spontaneously hypertensive rats. Neurourol Urodyn. 2017 Apr;36(4):1026-1033.
Density 1.24g/cm3
Boiling Point 505.5ºC at 760 mmHg
Melting Point 147 °C
Molecular Formula C27H32N2O6
Molecular Weight 480.553
Flash Point 259.5ºC
Exact Mass 480.226044
PSA 107.38000
LogP 3.67650
Vapour Pressure 2.41E-10mmHg at 25°C
Index of Refraction 1.648
Hazard Codes Xi

Chemsrc provides CAS#:242478-38-2 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 242478-38-2 | Chemsrc address: https://www.chemsrc.com/en/baike/755961.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved